| Literature DB >> 26386012 |
Sergio Portal-Núñez1, Juan Antonio Ardura1, Daniel Lozano2, Oskarina Hernández Bolívar3, Ana López-Herradón1, Irene Gutiérrez-Rojas4, Alexander Proctor5, Bram van der Eerden6, Marijke Schreuders-Koedam6, Johannes van Leeuwen6, María José Alcaraz7, Francisca Mulero8, Mónica de la Fuente3, Pedro Esbrit1.
Abstract
In the present study, the possibility that a diabetic (DM) status might worsen age-related bone deterioration was explored in mice. Male CD-1 mice aged 2 (young control group) or 16 months, nondiabetic or made diabetic by streptozotocin injections, were used. DM induced a decrease in bone volume, trabecular number, and eroded surface, and in mineral apposition and bone formation rates, but an increased trabecular separation, in L1-L3 vertebrae of aged mice. Three-point bending and reference point indentation tests showed slight changes pointing to increased frailty and brittleness in the mouse tibia of diabetic old mice. DM was related to a decreased expression of both vascular endothelial growth factor and its receptor 2, which paralleled that of femoral vasculature, and increased expression of the pro-adipogenic gene peroxisome proliferator-activated receptor γ and adipocyte number, without affecting β-catenin pathway in old mouse bone. Concomitant DM in old mice failed to affect total glutathione levels or activity of main anti-oxidative stress enzymes, although xanthine oxidase was slightly increased, in the bone marrow, but increased the senescence marker caveolin-1 gene. In conclusion, DM worsens bone alterations of aged mice, related to decreased bone turnover and bone vasculature and increased senescence, independently of the anti-oxidative stress machinery.Entities:
Keywords: Aging; Diabetes mellitus; Mice; Osteoporosis
Mesh:
Year: 2015 PMID: 26386012 DOI: 10.1093/gerona/glv160
Source DB: PubMed Journal: J Gerontol A Biol Sci Med Sci ISSN: 1079-5006 Impact factor: 6.053